WUHAN, March 4 (Xinhua) -- Clinical trials of drugs with possible positive effects on the novel coronavirus disease (COVID-19) are going smoothly and China is ready to share the results with the world, a Chinese medical expert said Wednesday. The trial for anti-HIV drug Lopinavir has ...
At present, relevant preparations for the industrialization of the Huashi Baidu granules have been made to fully meet the demand of the market, said Cheng Xueren, general manager of EFONG Pharmaceutical, a company affiliated with Sinopharm's China Traditional Chinese Medicine Holdings Co. Limited ("...
Engineered protein subunit COVID19 vaccine is as immunogenic as nanoparticles in mouse and hamster models Melissa M. Matthews ,Tae Gyun Kim &Matthias Wolf Article 24 October 2024|Open Access Hyaluronic acid dissolving microneedle patch-assisted acupoint transdermal delivery of triptolide for effective rh...
What is the best drug to treat COVID-19? The need for randomized controlled trialsThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the biggest public health challenge to the biomedical community of the last century. Despite multiple public health measures,1, 2, 3 ...
"If you look at access to medications for people who are uninsured, I think that there's no question that will widen those disparities," Rosenthal said. People who get insurance through their jobs could face high copays at the register, too, just as they do for insulin and other expensive...
As China continues to battle a surge in COVID-19 cases, pharmaceutical companies across the country have rushed to churn out ibuprofen, paracetamol and other fever medication."We are producing more than 10 times the number of ibuprofen injections compared to before December," sai...
(ECNS) -- China will launch a targeted campaign from January to June to secure stable prices and good quality of COVID-19 related drugs and medical supplies, according to an official of the country's top market watchdog. Luo Wen, head of the State Administration for Market Regulation, stre...
China's National Medical Products Administration approved its first treatment that specifically targets COVID-19. It uses a cocktail of two antibodies developed in China. Professor Zhang Linqi of Tsinghua University led the research team. Professor Zhang calls it cocktail therapy develo...
A research team at the Henan Normal University told media that they are trying to release in the domestic market an oral COVID-19 drug as soon as December. The drug named Azvudine is currently under phase III clinical trials in the First Affiliated Hospital of Zhengzhou University in ...
US decision hands biotech group its first regulatory blessing since its blockbuster Covid-19 jab May 7 2024 Drugs research MDMA-based mental health treatment faces wary US regulator Food and Drug Administration poised to call for outside assessment of Lykos PTSD therapy in test for psychedelics sec...